TBPH Rhonda Farnum sold Theravance Biopharma, Inc. shares — SEC Form 4SELLTheravance Biopharma, Inc.

Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc. (TBPH), sold 24,000 shares at $11.00 ($264K) on 2025-06-02, disclosed to the SEC on 2025-06-04.

SEC EDGAR Filing

0001415889-25-015642

View on SEC EDGAR

Trade context

Scheduled sale ($264k) by SVP, COMM & MEDICAL AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Notable60/100

Something here stands out, but not much.

Opportunistic SellUnusually Large Trade

Trade Context

•Decreased holdings by 7%
•3rd largest sale, out of 17
•Selling near 52-week high (+0% from peak)
•Stock up +23% in previous 3 months
•Part of a 10b5-1 trading plan

Filing Info

Filed2025-06-04

Traded2025-06-02

Accession0001415889-25-015642

SourceSEC EDGAR (Historical)

Insider

NameRhonda Farnum

TitleSVP, COMM & MEDICAL AFFAIRS

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
TBPH	SELL	2026-09-17	$227K	—	Filing →
TBPH	SELL	2026-06-17	$218K	—

Get an email when an insider at TBPH files

Free account. Follow TBPH and up to 10 more companies.

Follow TBPH for free

TBPH Rhonda Farnum sold Theravance Biopharma, Inc. shares — SEC Form 4SELLTheravance Biopharma, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes